Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
Unauthorized sexual enhancement products seized from Yonge and John Medical Pharmacy in Thornhill, ON
- Starting date:
- May 15, 2017
- Type of communication:
- Source of recall:
- Health Canada
- Identification number:
- Products affected
- What you should do
- Who is affected
- Media enquiries
- Public enquiries
- What Health Canada is doing
Health Canada is advising Canadians that the unauthorized health products “Black Mamba 2 Premium” and “ExtenZe” are labelled to contain drugs that may pose serious health risks (DHEA, pregnenolone, and yohimbe/yohimbine). Health Canada seized the products, which are promoted for sexual enhancement, from Yonge and John Medical Pharmacy at 7670 Yonge Street in Thornhill, ON.
- Black Mamba 2 Premium (yohimbe)
- ExtenZe (DHEA, pregnenolone, and yohimbe bark extract)
What you should do
- Stop using these products. Consult with your health care professional if you have used any of these products and have health concerns.
- Read product labels to verify that health products have been authorized for sale by Health Canada. Authorized health products have an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN) or Homeopathic Drug Number (DIN-HM). You can also check whether products have been authorized for sale by searching Health Canada’s Drug Product Database and Licensed Natural Health Product Database.
- Report adverse events to health products to Health Canada by calling toll-free at 1 866 234 2345, or by reporting online, by mail or by fax.
- Report complaints about health products to Health Canada by calling toll-free at 1 800 267 9675, or complete an online complaint form.
Who is affected
Consumers who have bought or used any of these products.
DHEA is a controlled drug that can cause higher than normal levels of female and male hormones in the body and could increase the risk of prostate, breast, ovarian, and other hormone-sensitive cancers. Potential side effects include serious cardiovascular disease, as well as changes in fertility and sperm production. DHEA should be avoided by individuals with a history of abnormal heart rhythms, blood clotting disorders, liver disease and those who are pregnant or breast-feeding.
Pregnenolone is a prescription drug that can cause higher than normal levels of female and male hormones in the body and could increase the risk of prostate, breast, ovarian, and other hormone-sensitive cancers. Pregnenolone should not be used by women who are pregnant or breast-feeding, and should be avoided by individuals who suffer from epileptic seizures or who are taking anti-seizure medications.
Yohimbine is a prescription drug and should be used only under the supervision of a health care professional. Yohimbine is derived from yohimbe, a bark extract. The use of yohimbine or yohimbe may result in serious adverse reactions, particularly in people with high blood pressure, or heart, kidney or liver disease. Side effects include increased blood pressure and heart rate, anxiety, dizziness, tremors, headache, nausea and sleep disorders. It should not be used by children, or pregnant or nursing women.
What Health Canada is doing
Health Canada seized the products from the retail location. Should additional retailers or distributors be identified, Health Canada will take appropriate action and inform Canadians.
Select thumbnail to enlarge - opens in a new window
- Date modified: